Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Total Current Liabilities (2022 - 2025)

Historic Total Current Liabilities for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $22.3 million.

  • InflaRx's Total Current Liabilities rose 4623.53% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year increase of 4623.53%. This contributed to the annual value of $15.3 million for FY2024, which is 1539.7% down from last year.
  • InflaRx's Total Current Liabilities amounted to $22.3 million in Q3 2025, which was up 4623.53% from $18.3 million recorded in Q2 2025.
  • InflaRx's Total Current Liabilities' 5-year high stood at $22.3 million during Q3 2025, with a 5-year trough of $7.3 million in Q1 2023.
  • Over the past 4 years, InflaRx's median Total Current Liabilities value was $13.3 million (recorded in 2022), while the average stood at $14.3 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first crashed by 6568.91% in 2023, then skyrocketed by 7228.19% in 2024.
  • InflaRx's Total Current Liabilities (Quarter) stood at $13.3 million in 2022, then soared by 36.37% to $18.1 million in 2023, then dropped by 16.47% to $15.1 million in 2024, then soared by 47.14% to $22.3 million in 2025.
  • Its last three reported values are $22.3 million in Q3 2025, $18.3 million for Q2 2025, and $17.0 million during Q1 2025.